These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11690567)

  • 1. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
    Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
    Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of electrical cardioversion in patients with previous embolic events.
    Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
    Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
    Mehta D; Baruch L
    Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.
    Arnold AZ; Mick MJ; Mazurek RP; Loop FD; Trohman RG
    J Am Coll Cardiol; 1992 Mar; 19(4):851-5. PubMed ID: 1545081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of electrical cardioversion in patients with atrial fibrillation.
    Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
    Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioversion of atrial arrhythmias: audit of anticoagulation management.
    Mayet J; Wasan B; Sutton GC
    J R Coll Physicians Lond; 1997; 31(3):313-6. PubMed ID: 9192336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
    Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
    J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
    Berger M; Schweitzer P
    Am J Cardiol; 1998 Dec; 82(12):1545-7, A8. PubMed ID: 9874066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolism in chronic atrial flutter: is the risk underestimated?
    Lanzarotti CJ; Olshansky B
    J Am Coll Cardiol; 1997 Nov; 30(6):1506-11. PubMed ID: 9362409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thromboembolic events in patients with atrial flutter.
    Seidl K; Hauer B; Schwick NG; Zellner D; Zahn R; Senges J
    Am J Cardiol; 1998 Sep; 82(5):580-3. PubMed ID: 9732883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
    Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE
    Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of direct current cardioversions for atrial arrhythmia.
    Johnston SD; Trouton TG; Wilson C
    Ulster Med J; 1998 May; 67(1):19-24. PubMed ID: 9652194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic anticoagulation of atrial flutter prior to cardioversion: meeting the "burden of proof".
    Silverman DI; Manning WJ
    Am J Med; 2001 Oct; 111(6):493-4. PubMed ID: 11690577
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.
    Wall C; Jankowski T; Naruka V; Mota P
    PLoS One; 2019; 14(1):e0210170. PubMed ID: 30605492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.